Equifax Inc. (NYSE:EFX – Free Report) by 14.6% during the 4th quarter, Holdings Channel.com reports. The fund owned 41,969 ...
In a report released yesterday, Owen Lau from Oppenheimer maintained a Buy rating on Equifax (EFX – Research Report), with a price target of ...
Akero's SYMMETRY Phase 2b study showed 50mg EFX achieved 24% cirrhosis reversal in MASH patients, with improvements in liver ...
Chicago Partners Investment Group LLC decreased its position in shares of Equifax Inc. (NYSE:EFX – Free Report) by 35.8% ...
Analysts have been eager to weigh in on the Industrial Goods sector with new ratings on Equifax (EFX – Research Report) and Werner Enterprises ...
Akero Therapeutics reports a 39% improvement in cirrhosis patients using EFX. See why AKRO stock is soaring with the ...
February 05, 2025, 09:17 AM ET, BY Billy, Contributor | Editor: Derek Curry ( Follow on LinkedIn ) ...
1d
Stocktwits on MSNEquifax Stock Dives After Q4 Earnings, 2025 Guidance Miss Estimates: Retail Cheers Dividend Payment For 100-Plus Consecutive YearsShares of data analytics firm Equifax Inc (EFX) fell nearly 7% on Thursday, heading toward their worst single-day session ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results